Cost, Accessibility, and Insurance Coverage Access and affordability remain major challenges
These medications originated to treat type 2 diabetes , and were later approved in the US for weight loss by the Food and Drug Administration (FDA) under Ozempic and Wegovy brand names
They stated, the WHO Advisory Committee on Safety of Medicinal Products (ACSoMP)...concluded that the Risk Management Plan for semaglutide should be revised to include NAION as a potential risk, including any required additional pharmacovigilance activities. 06.17.25 Plaintiffs seek to have NJ host vision loss lawsuits A group of 21 New Jersey State Court plaintiffs are seeking to consolidate their vision loss lawsuits as multicounty litigation
Disha Narang, M.D., endocrinologist and director of obesity medicine at Endeavor Health in Skokie, IL
After the initial four weeks, the dosage is increased to 1 mg once weekly